Aiba T, Itoga Y, Shimizu H, Tanigawara Y, Hori R
Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Japan.
J Pharm Sci. 1994 May;83(5):723-6. doi: 10.1002/jps.2600830526.
The renal handling of tobramycin (TOB), an aminoglycoside antibiotic (AG), was studied using a single-pass isolated perfused rat kidney with moment analysis. In the bolus administration study at tracer concentration (7.4 microM), 32% of the glomerular-filtrated TOB remained in the lumen, but no TOB was found in the vein. This ratio of the luminal uptake was reduced in a dose-dependent manner. Other aminoglycosides such as gentamicin inhibited this uptake, but tetraethylammonium and glucosamine had no effect. In addition, under the alkalinuria condition, TOB uptake was decreased to 67% of the control value. This indicated that TOB has mainly been taken into the renal epithelial cells from their luminal site and that this uptake process was saturable and specific for AGs which have more than one cationic group. The present findings should be helpful in developing a method to reduce the nephrotoxicity of AGs and to identify their toxicity mechanisms.
采用单通道离体灌注大鼠肾脏并进行矩分析,研究了氨基糖苷类抗生素妥布霉素(TOB)的肾脏处理过程。在示踪剂浓度(7.4微摩尔)下的推注给药研究中,32%的经肾小球滤过的TOB留在管腔内,但在静脉中未发现TOB。这种管腔摄取率呈剂量依赖性降低。庆大霉素等其他氨基糖苷类抗生素可抑制这种摄取,但四乙铵和葡糖胺则无作用。此外,在碱尿症情况下,TOB摄取降至对照值的67%。这表明TOB主要是从管腔部位被肾上皮细胞摄取,并且这种摄取过程是可饱和的,对具有多个阳离子基团的氨基糖苷类抗生素具有特异性。目前的研究结果有助于开发一种降低氨基糖苷类抗生素肾毒性的方法,并确定其毒性机制。